A CLINICAL STUDY TO RULE OUT THE EFFECT OF GUD HARITAKI AND PUNARNAVA MANDUR IN THE MANAGEMENT OF PANDU ROGA W.S.R. TO IRON DEFICIENCY ANAEMIA AMONG CHILDREN

A CLINICAL STUDY TO DETERMINE THE ROLE OF GUD HARITAKIAND PUNARNAVA MANDURIN THE MANAGEMENT OF PANDU ROGA W.S.R. TO IRON DEFICIENCY ANAEMIA AMONG CHILDREN -

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021586

Enrollment

Registered

2019-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- age 11yrs to 16 yrs HB 11 gm %

Interventions

Intervention1: PUNARNAVA MANDURA: 500mg twice a day orally 4 weeks duration reference ch.chi.16/93-96 Control Intervention1: GUD HARITAKI: Guda haritaki 500mg/kg devided in two doses orally 4 weeks

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children with Iron Deficiency Anaemia having Hb levels between 7-11 gm%. 2. Patients willing and able to participate for 6 weeks duration.

Exclusion criteria

Exclusion criteria: 1.Children havingHb levels 11 gm%. 2.Children suffering from major systemic illness necessitating long term drug treatment. 3.Children having co- morbidities like tuberculosis, chronic urinary tract infection, bleeding disorders etc. 4.History of hypersensitivity to any of the trial drug or their ingredients. 5.Children who have completed participation in any other clinical trial during the past six months.

Design outcomes

Primary

Measure	Time frame
HB GM % INCREASETimepoint: 6 WEEKS	—

Secondary

Measure	Time frame
DIMINISHED SYMPTOMSTimepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactSHAILENDRA KUMAR

RAJIV GANDHI AYURVEDIC COLLEHE AND HOSPITAL PAPROLA DISTRICT KANGRA HIMACHAL PRADESH

drminakshi2050@gmail.com9418017565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026